A novel synthesis of acyclonucleosides via allylation of 3-[1-(phenylhydrazono)-L-threo-2,3,4-trihydroxybut-1-yl]quinoxalin-2(1H)one

Carbohydrate Research

Volumn 338, Issue 22, 2003, Pages 2301-2309

  Hamid, Hamida Mohamed Abdel ^a  

^a Alexandria University Faculty Of Science   (Egypt)

Author keywords

Acyclonucleosides; Allyl bromide; Allylation; NaH DMF; Pyrazolylquinoxaline

Indexed keywords

ACETIC ACID; ACETYLATION; SPECTRUM ANALYSIS; SYNTHESIS (CHEMICAL); VIRUSES;

ALLYLATION;

NUCLEIC ACIDS;

1 N (2,3 DIBROMOPROPYL) 3 [5 (HYDROXYMETHYL) 1 (4 BROMOPHENYL)PYRAZOL 3 YL]QUINOXALIN 2 ONE; 1 N ALLYL 3 [1 (PHENYLHYDRAZONO) LEVO THREO 2,3,4 TRIHYDROXYBUT 1 YL]QUINOXALIN 2 ONE; 1 N ALLYL 3 [3,4 DI O ACETYL 2 DEOXY 1 (PHENYLHYDRAZONO)BUT 2 EN 1 YL]QUINOXALIN 2 ONE; 1 N ALLYL 3 [5 (ACETOXYMETHYL) 1 PHENYLPYRAZOL 3 YL]QUINOXALIN 2 ONE; 1 N ALLYL 3 [5 (HYDROXYMETHYL) 1 PHENYLPYRAZOL 3 YL]QUINOXALIN 2 ONE; 2 ACETOXY 3 [5 (ACETOXYMETHYL) 1 PHENYLPYRAZOL 3 YL]QUINOXALINE; 2 O ALLYL 3 [5 (HYDROXYMETHYL) 1 PHENYLPYRAZOL 3 YL]QUINOXALINE; 3 [1 (PHENYLHYDRAZONO) LEVO THREO 2,3,4 TRIHYDROXYBUT 1 YL]QUINOXALIN 2(1H) ONE; ANTIVIRUS AGENT; NUCLEOSIDE DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ALLYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG ACETYLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY;

HEPATITIS B VIRUS;

EID: 0142138721     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6215(03)00376-8     Document Type: Article

References (36)

1. St Clair, R. L.; Thibault, T. D. Ger. Offen. 2, 459, 453 (1975) [C.A., 83, 164237 (1975)]
2. Yamamoto, H. Jap. Pat. 69, 17, 136. (1969) [C.A., 71, 124505d (1969)].
3. Zeliner, H.; Pailer, M.; Prukmayr, G., Austrian Pat. 228, 204 (1963) [C.A., 59, 11514 (1963)].
4. Yellin, T. O., U. S. Pat. 3, 635, 971 (1972) [C. A., 76, 99708r (1972)].
5. Fisons Pest Control Ltd., Belg. Pat. 631, 044 (1963) [C.A., 60, 15891 (1964)].
6. Higgins ans J., Menon C.S. J. Polym. Sci. (B). 10:1972;129-131.
7. Biere H., Bottcher I., Kapp J.F. Arch. Pharm. 316:1983;588-597.
8. Georgescu C., Dumitrescu C., Danau M., Spandonidis S., Costache G. Med. Intern. 24:1986;147.
9. Muller P., Dammann H.G., Simon B. Arzneim. -Forsch. 36:1986;1399-1400.
10. Vinge E., Bjorkman S. Acta Pharmacol. Toxicol. (Copenh.). 59:1986;165-174.
11. El Ashry, E. S. H., in P. A. Seib, B. M. Tolbert (Eds.), Ascorbic Acid Chemistry, Metabolism and Uses. vol. 200, American Chemical Society Washington, DC, 1982, pp. 179-186.
12. El Ashry E.S.H., Mousaad A., Rashed N. Adv. Heterocycl. Chem. 53:1992;233-312.
13. Rashed N., Abdel Hamid H., El Ashry E.S.H. Carbohydr. Res. 243:1993;399-405.
14. Amer A., El Massry A.M., Awad L., Rashed N., El Ashry E.S.H., HO D.M. J. Chem. Soc. Perkin Trans. 1. 1990;2513-2518.
15. Chu C.K., Cutler S.J. J. Heterocylc. Chem. 23:1986;289-319.
16. MacCoss M., Tolman R. L., Ashton W.T., Wagner A.F., Hannah J., Field A.K., Karkas J.D., Germershausen J.I. Chem. Scr. 26:1986;113.
17. Yokoyama, M.; S. Watanabe, Yuki Gosei Kagaku Kyokaishi 47, 694 (1989)[C.A. 11, 98984c (1990)].
18. Balzarini J., De Clercq E. Pharmaco. Chem. Libr. 14:1990;175-194.
19. Chu C.K., Baker D.C. Nucleosides and Nucleotides as Antitumor and Antiviral Agents. 1993;Plenum Press, New York.
20. El Ashry E.S.H., El Kilany Y. Adv. Heterocycl. Chem. 69:1998;129-215.
21. El Ashry E.S.H., El Kilany Y. Adv. Heterocycl. Chem. 68:1997;1-88.
22. El Ashry E.S.H., El Kilany Y. Adv. Heterocycl. Chem. 67:1996;391-438.
23. El Ashry E.S.H., Rashed N., Abdel Hamid H., Ramadan E.S. Z. Naturforsch. 52b:1997;873-882.
24. Rashed N., Abdel Hamid H., Ramadan E.S., El Ashry E.S.H. Nucleosides Nucleotides. 17:(8):1998;1373-1384.
25. Henseke G., Dittrich K. Chem. Ber. 92:1959;1550-1558.
26. Henseke G. Z. Chem. 6:1966;329-336.
27. El Ashry E.S.H., El Kholy I.E., El Kilany Y. Carbohydr. Res. 60:1978;303-314.
28. El Ashry E.S.H., El Kholy I.E., El Kilany Y. Carbohydr. Res. 60:1978;396-399.
29. El Ashry E.S.H., El Kholy I.E., El Kilany Y. Carbohydr. Res. 67:1978;495-499.
30. Baldwin J.J., Raab A.W., Mensler K., Arison B.H., Mcclure D.E. J. Org. Chem. 43:1978;4876-4878.
31. El Ashry E.S.H. J. Chem. Soc. Chem. Commun. 1986;1024-1026.
32. El Ashry E.S.H., Abdel Hamid H., El Habrouk M. Carbohydr. Res. 267:1995;177-186.
33. Sells M.A., Chen M.L., Acs G. Proc. Natl. Acad. Sci. USA. 84:1987;1005.
34. Doong S.L., Tsai C.H., Schinazi R.F., Liotta D.C., Cheng Y.C. Proc. Natl. Acad. Sci. USA. 88:1991;8495-8499.
35. Korba B.E., Gerin J.L. Antiviral Res. 19:1992;55-70.
36. Fouad T., Nielsen C., Brunn L., Pedersen E.B. Sc. J. Az. Med. Fac. (GIRLS). 19:1998;1173-1187.